150 related articles for article (PubMed ID: 28570931)
1. IL-17A causes depression-like symptoms via NFκB and p38MAPK signaling pathways in mice: Implications for psoriasis associated depression.
Nadeem A; Ahmad SF; Al-Harbi NO; Fardan AS; El-Sherbeeny AM; Ibrahim KE; Attia SM
Cytokine; 2017 Sep; 97():14-24. PubMed ID: 28570931
[TBL] [Abstract][Full Text] [Related]
2. Worsening of imiquimod-induced psoriasiform inflammation in mice by environmental pollutant, di-(2-ethylhexyl) phthalate through dysregulation in IL-17A and Nrf2/iNOS signaling in peripheral myeloid and CD4 + T cells.
Alfardan AS; Nadeem A; Ahmad SF; Al-Harbi NO; Alqinyah M; Attia SM; Sarawi W; Alanazi AZ; Alhazzani K; Ibrahim KE
Int Immunopharmacol; 2024 Jan; 126():111293. PubMed ID: 38056199
[TBL] [Abstract][Full Text] [Related]
3. LY294002 ameliorates psoriatic skin inflammation in mice via blocking the Notch1/Hes1-PTEN/AKT/IL-17A feedback loop.
Lin Y; Zhu X; Li Y; Dou Y; Wang J; Qi R; Ma L
Clin Exp Immunol; 2023 Jul; 213(1):114-124. PubMed ID: 36840628
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species produced by myeloid cells in psoriasis as a potential biofactor contributing to the development of vascular inflammation.
Schaller T; Ringen J; Fischer B; Bieler T; Perius K; Knopp T; Kommoss KS; Korn T; Heikenwälder M; Oelze M; Daiber A; Münzel T; Kramer D; Wenzel P; Wild J; Karbach S; Waisman A
Biofactors; 2023; 49(4):861-874. PubMed ID: 37139784
[TBL] [Abstract][Full Text] [Related]
5. Celastrol regulates psoriatic inflammation and autophagy by targeting IL-17A.
Park A; Heo TH
Biomed Pharmacother; 2024 Mar; 172():116256. PubMed ID: 38367550
[TBL] [Abstract][Full Text] [Related]
6. The m
Yuan L; Chen S; Ding K; Wang X; Lv W; Liu Y; He S; Yu Y; Yang B; Huang T
Exp Dermatol; 2024 Jan; 33(1):e14879. PubMed ID: 37434495
[TBL] [Abstract][Full Text] [Related]
7. The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis.
Mavropoulos A; Rigopoulou EI; Liaskos C; Bogdanos DP; Sakkas LI
Clin Dev Immunol; 2013; 2013():569751. PubMed ID: 24151518
[TBL] [Abstract][Full Text] [Related]
8. IL-17A is involved in the hyperplasia of blood vessels in local lesions of psoriasis by inhibiting autophagy.
Wang J; Zhou L; Hou H; Li J; Zhao X; Li J; Li J; Niu X; Hou R; Zhang K
J Cosmet Dermatol; 2024 Jan; 23(1):326-338. PubMed ID: 37635345
[TBL] [Abstract][Full Text] [Related]
9. Targeting STING in dendritic cells alleviates psoriatic inflammation by suppressing IL-17A production.
Sun X; Liu L; Wang J; Luo X; Wang M; Wang C; Chen J; Zhou Y; Yin H; Song Y; Xiong Y; Li H; Zhang M; Zhu B; Li X
Cell Mol Immunol; 2024 May; ():. PubMed ID: 38806624
[TBL] [Abstract][Full Text] [Related]
10. IL-23 induces CLEC5A
Furuya H; Nguyen CT; Chan T; Marusina AI; Merleev AA; Garcia-Hernandez ML; Hsieh SL; Tsokos GC; Ritchlin CT; Tagkopoulos I; Maverakis E; Adamopoulos IE
J Autoimmun; 2024 Feb; 143():103167. PubMed ID: 38301504
[TBL] [Abstract][Full Text] [Related]
11. Blocking IL-17A prevents oxycodone-induced depression-like effects and elevation of IL-6 levels in the ventral tegmental area and reduces oxycodone-derived physical dependence in rats.
Inan S; Meissler JJ; Bessho S; Wiah S; Tukel C; Eisenstein TK; Rawls SM
Brain Behav Immun; 2024 Mar; 117():100-111. PubMed ID: 38199516
[TBL] [Abstract][Full Text] [Related]
12. Obesity-induced dysregulation of skin-resident PPARγ
Sivasami P; Elkins C; Diaz-Saldana PP; Goss K; Peng A; Hamersky M; Bae J; Xu M; Pollack BP; Horwitz EM; Scharer CD; Seldin L; Li C
Immunity; 2023 Aug; 56(8):1844-1861.e6. PubMed ID: 37478855
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors of atopic-like dermatitis induced by IL-17A inhibitors in patients with psoriasis: A 2-year follow-up study.
Tang X; Li Q; Zhou Y; Zheng X; Zhou C; Hu Y; Wang P; Chen A; Huang K
J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):2509-2516. PubMed ID: 37528440
[TBL] [Abstract][Full Text] [Related]
14. Effects on peripheral and central nervous system of key inflammatory intercellular signalling peptides and proteins in psoriasis.
Tang J; Zhao S; Shi H; Li X; Ran L; Cao J; He Y
Exp Dermatol; 2024 May; 33(5):e15104. PubMed ID: 38794817
[TBL] [Abstract][Full Text] [Related]
15. A co-assembly platform engaging macrophage scavenger receptor A for lysosome-targeting protein degradation.
Wang Q; Yang X; Yuan R; Shen A; Wang P; Li H; Zhang J; Tian C; Jiang Z; Li W; Dong S
Nat Commun; 2024 Feb; 15(1):1663. PubMed ID: 38396109
[TBL] [Abstract][Full Text] [Related]
16. Serum Beta-Defensin-2 is a biomarker for psoriasis but not subclinical atherosclerosis: Role of IL17a, PI-3 kinase and Rac1.
Pantoja CJ; Li H; Rodante J; Keel A; Sorokin AV; Svedbom A; Teague HL; Stahle M; Mehta NN; Playford MP
JEADV Clin Pract; 2024 Mar; 3(1):150-159. PubMed ID: 38646149
[TBL] [Abstract][Full Text] [Related]
17. The CD147 expression in CD4
Liu P; Li L; Kuang Y; Zhu W; Li J; Chen X; Peng C
Clin Transl Med; 2024 Feb; 14(2):e1568. PubMed ID: 38303607
[No Abstract] [Full Text] [Related]
18. NFκB inhibitors as a potential novel hypothesized treatment for psoriasis.
Derakhshan N
Sao Paulo Med J; 2011 Dec; 129(6):433-4. PubMed ID: 22249801
[No Abstract] [Full Text] [Related]
19. A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation.
Mehdi S; Wani SUD; Krishna KL; Kinattingal N; Roohi TF
Biochem Biophys Rep; 2023 Dec; 36():101571. PubMed ID: 37965066
[TBL] [Abstract][Full Text] [Related]
20. Brief Report: Interleukin-17A-Dependent Asymmetric Stem Cell Divisions Are Increased in Human Psoriasis: A Mechanism Underlying Benign Hyperproliferation.
Charruyer A; Fong S; Vitcov GG; Sklar S; Tabernik L; Taneja M; Caputo M; Soeung C; Yue L; Uchida Y; Arron ST; Horton KM; Foster RD; Sano S; North JP; Ghadially R
Stem Cells; 2017 Aug; 35(8):2001-2007. PubMed ID: 28600817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
